Weimin Peng, Ms, PhD
About Weimin Peng, Ms, PhD
Weimin Peng is the Director of Biostatistics at Kite Pharma, where he has worked since 2017. He has a strong background in biostatistics and has contributed to significant regulatory submissions in oncology.
Work at Kite Pharma
Weimin Peng has served as the Director of Biostatistics at Kite Pharma since 2017. In this role, he oversees statistical methodologies and analyses for clinical trials, contributing to the development of innovative therapies. His expertise in biostatistics supports the company's mission to advance cell therapy treatments. His leadership in statistical strategy is essential for regulatory submissions and the overall success of clinical programs.
Previous Experience in Biostatistics
Prior to his current position, Weimin Peng worked at Johnson & Johnson as a Principal Statistician from 2010 to 2017. During this time, he led statistical efforts for various clinical studies, particularly in oncology. He also held a part-time position as a Statistician at the UCLA Fielding School of Public Health from 2009 to 2010, where he applied his statistical skills in public health research.
Education and Expertise
Weimin Peng holds a Doctor of Philosophy (PhD) in Biophysics from Tsinghua University. He also earned a Master's degree in Biostatistics from the University of California, Los Angeles. Additionally, he completed a Postdoctoral Research Associate position at Duke University, further enhancing his expertise in statistical analysis and research methodologies.
Contributions to Clinical Research
Throughout his career, Weimin Peng has made significant contributions to clinical research. He played a key role in the US submission of Yondelis for soft tissue sarcoma and supported the regulatory submission of Zytiga for prostate cancer. His involvement as the lead statistician in multiple phase 1, 2, and 3 clinical studies has been pivotal in advancing treatments for prostate and breast cancer.
Postdoctoral Research Experience
Weimin Peng's postdoctoral research experience includes a position at the David Geffen School of Medicine at UCLA from 2004 to 2008. This four-year tenure allowed him to deepen his research skills and apply statistical methods in a medical context. He also worked as a Postdoctoral Research Associate at Duke University from 2001 to 2004, where he further developed his expertise in biostatistics.